CTIC(Delisted)
CTI BioPharma·NASDAQ
--
--(--)
CTIC fundamentals
CTI BioPharma (CTIC) released its earnings on Nov 7, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 7, 2017
EPS
Revenue
Revenue & Expenses
CTIC has released its 2023 Q1 earnings report, with revenue of 24.12M, reflecting a YoY change of 950.81%, and net profit of -13.42M, showing a YoY change of 63.90%. The Sankey diagram below clearly presents CTIC's revenue sources and cost distribution.
Key Indicators
CTI BioPharma (CTIC) key financial stats and ratios, covering profitability, financial health, and leverage.
CTI BioPharma (CTIC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CTI BioPharma (CTIC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CTI BioPharma (CTIC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CTI BioPharma (CTIC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CTI BioPharma (CTIC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
